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Abstract-A community study of more than 3000 persons screened in the Burgh of Renfrew, 
Scotland, included 1134 men age 4%54 whose baseline casual glucose level was measured in 1972 
and who were followed for 6 yr to determine mortality rate. A positive association was found, in 
univariate analysis, between baseline glucose level and prevalence of ECG abnormalities as 
defined both by the London Whitehall Study and the U.S. Pooling Project Study. In multivariate 
analyses of these cross-sectional data, an association was seen for Whitehall but not Pooling 
Project abnormalities. No association was found between asymptomatic hyperglycemia and 
coronary mortality at 6 yr, either in univariate, bivariate or multivariate analyses. The climcally- 
observed excess in coronary mortality among those with symptomatic diabetes mellitus was not 
m evidence among those with asymptomatic hyperglycemia in this group of middle-aged men. 
INTRODUCTION 
ELUCIDATION of the relationship of hyperglycemia to coronary heart disease requires the 
examination of many thousands of subjects and their observation over many years. An 
alternative to large-scale studies, such as those now in progress in mild to moderate 
hypertension Cl], offering a possibility of obtaining conclusive data within a reasonable 
time, is the parallel examination of comparable data from many centers. The Scottish 
contribution was a data set comprising prevalence rates of ECG abnormalities at base- 
line and 6 yr mortality as related to casual blood glucose in a sub-group of a larger study 
on the natural history and prevention of cardio-respiratory disease in the West of Scot- 
land. 
METHODS 
The sample comprised 3000 people aged between 45 and 64yr on 1 January 1972, 
identified by census as residents in the Burgh of Renfrew near Glasgow in the West of 
Scotland [2]. This represented a response rate of 78.7%. The sample was examined by 
multiphasic screening in March 1972, as part of a prospective study of the general 
population. The study was designed primarily to observe the effects of stopping smoking 
in the 10% at high risk from cardio-respiratory disease and also to examine the feasibility 
of accelerating the decline of tuberculosis [3]. 
All examinees completed a standard questi0nnaire.S Height and weight were measured 
and forced expiratory volume in 1 set using a Garthur Vitalograph. A six-lead electrocar- 
diogram (leads I, II, III, aVR, aVL and aVF) was made with the subject sitting. ‘Blood 
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pressure was measured with the subject seated, using the London School of Hygiene and 
Tropical Medicine sphygmomanometer [4] with a cuff of 12 x 22 cm. Diastolic was 
taken at the disappearance of the fifth Korotkoff sound. Observers had been trained to 
measure blood pressure using special tape records [SJ. Finally a tuberculin Tine test 
(Lederle) was made and a 70 mm chest X-ray taken. 
Blood samples were collected afternoons and evenings. A 10 ml casual sample of 
venous blood was taken without venous stasis and plasma total cholesterol measured by 
an autoanalyser technique [6]. Glucose was determined (using whole blood) by the 
measurement of oxygen consumption [7]. 
Among 1394 males aged between 45 and 64 yr on the date of screening, 14 were known 
diabetics. Since interest in this investigation centered on asymptomatic hyperglycemia, 
these men were not included in this analysis. In addition, 214 men on anti-hypertensive 
medication at baseline were excluded from the main analyses, since such medication 
could have altered glucose level. (However, to ascertain whether such exclusion might 
have biased the findings, the multiple logistic was calculated both excluding and includ- 
ing them.) In addition, 32 other men were excluded who had data missing on variables 
relevant to this investigation. The remaining 1134 men form the main study group for the 
purpose of these analyses. 
Diabetes was determined by response to questionnaire. Only those answering ‘yes’ to 
the question “Are you, or have you ever been diabetic?“, or failing to answer, were 
excluded. Relative weight was calculated as actual weight expressed as a proportion of 
ideal weight for height and sex, as defined from the Metropolitan Life Insurance Com- 
pany Tables [8]. 
For the analyses relating glucose to mortality, six men having ECG evidence at base- 
line of myocardial infarction (Minnesota Codes 1.1, 1.2) [9], were excluded leaving 1128 
men for those analyses. 
ECG abnormalities were classified in three groups by Minnesota Code [lo] : myocar- 
dial infarction-codes 1.1 and 1.2; Whitehall Study criteria for abnormalities-codes 
1.1-1.3, 4.1-4.4, 5.1-5.3 and 7.1; and U.S. Pooling Project Major Abnormalities<odes 
1.1, 1.2, 4.1, 4.2, 5.1, 5.2, 6.1, 6.2, 7.1, 7.2, 7.4, 8.1 and 8.3. 
The eighth revision of the International Classification of Disease [ll] was used to 
classify mortality-provided by the N.H.S. Register of the Registrar General for Scot- 
land. Three mortality endpoints were used: 
1. All mortality; 
2. Cardiovascular mortality (ICD 390-458); 
3. Coronary heart disease mortality (ICD 410-414). 
Rates of ECG abnormalities and mortality rates for the group as a whole were com- 
puted by age-averaging the rates for the four 5-yr age groups. 
RESULTS 
Table 1 shows the age distribution of the main study group, as well as of those 
excluded and displays the numbers excluded for the stated reasons. 
TABLE 1. CHARACIERISXS OF STUDY POPULATION, RENFREW, SCOTLAND 
Number Exclusions 
of Antihypertensive Missing Study 
Age group men Diabetics treatment data group 
45-49 389 2 58 10 319 
so-54 375 3 51 6 315 
55-59 346 6 55 6 279 
284 3. 50 10 221 
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TABLE 3. SIMPLE CORRELATION 
COEFFICIENTS WITH GLUCOSE IN 

























*p < 0.05. 
**p < 0.01. 
***p 5 0.001. 
Table 2 gives means and standard deviations, by age group, for the 8 variables of 
interest-age, systolic blood pressure, diastolic blood pressure, serum cholesterol, glu- 
cose, relative weight, number of cigarettes smoked per day by all men and number of 
cigarettes smoked per day by smokers only. 
Table 3 gives simple correlation coefficients with glucose for each of the other vari- 
ables. Glucose was significantly positively correlated with systolic blood pressure 
(p < O.OOl), with relative weight (p < 0.001) and with cigarette smoking (p < 0.01). 
Although these correlations were statistically significant, they were of low order. 
Tables 4-6 show the relationship between glucose level and prevalence of ECG abnor- 
malities. The number of myocardial infarctions were, in each table, too small to permit 
meaningful statistical analysis. 
Table 4 shows age-adjusted ECG prevalence rates for the quintiles and extreme values 
of glucose for the study group. There was a trend for higher levels of glucose to be 
associated with a higher abnormality rate for both Pooling Project Major and Whitehall 
abnormalities. A chi-squared test for linear trend in abnormality rate yielded a significant 
result for the Whitehall group (p < 0.05). The test for departures from linearity was 
non-significant, indicating that a straight line is an adequate fit. 
TABLE~.QUIN'IILE~,EX~R~MEVALUESOFCLUCOSE AND PREVALENCEOF ECG ABNOR- 
MALITIES, 1134=, AGE 45-64, RENFREW,%O'ILAND 
Glucose Number Prevalence of ECG abnormality 
Quintile of range of Whitehall Pooling Project 



















8t 401 10 46 
13 60 11 49 
16 77 12 58 
16 70 16 79 
19 89 16 73 
2 35 1 16 
9 153 7 123 
72 66 65 60 
*Significant linear trend. 
tNumber of abnormalities. 
IStandardized prevalence rate per 1000. 
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TABLE 5. GLUCOSE, SYSTOLIC BLOOD PRESSURE AND PREVALENCE OF ECG ABNORMALITIES, 1134 MEN, AGE 45-64, 
RENFREW, SCOTLAND 
Systolic blood 








Prevalence of ECG abnormality 
Whitehall Pooling Project 
Criteria Major Abnormalities 
SBP below median (i 146) 
Qumtile 
* 
27-80 128 4t 451 6 60 
81-88 148 3 24 4 30 
89-96 104 7 73 6 65 
97-107 105 9 78 5 58 
108-518 97 7 85 6 66 






SBP above median (> 146) 
Quintile 
1 27780 96 4 39 4 
81-88 93 10 98 7 
89-96 107 9 87 6 
97-107 127 7 56 11 
108-518 131 12 96 10 
27-518 552 42 74 38 












*Significant linear trend. 
tNumber of abnormalities. 
IStandardIzed rate per IOCO 
Table 5 divides the study group into two systolic blood pressure groups using the 
median systolic blood pressure as cutting point, and shows age-adjusted ECG prevalence 
rates for the quintiles of glucose. A chi-squared test of linear trend in abnormality rates 
gave a significant result for the Whitehall group with systolic blood pressure below the 
median (JJ < 0.05). Again the straight line was shown to be an adequate fit. There was a 











Prevalence of ECG abnormality 
Whitehall Pooling Project 



















27-80 40 2* S8t 4 91 
81-88 52 0 0 1 23 
89-96 66 7 107 4 59 
97-107 61 2 32 1 15 
108-518 54 4 72 3 49 
27-518 273 15 57 13 52 
27-80 123 3 35 3 29 
81-88 123 8 79 6 54 
89-96 97 6 63 6 66 
97-107 104 7 69 9 93 
108-518 96 6 70 7 70 
27-518 543 30 62 31 64 
27-80 61 3 49 3 49 
81-88 66 5 81 4 64 
89-96 48 3 66 2 36 
97-107 65 7 99 6 88 
108-518 78 9 123 6 86 
27-518 318 27 84 21 65 







*Number of deaths. 
tstandardized death rate per 1000. 
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TABLE 7. MULTIPLE LOGISTIC ANALYSIS, PREVALENCE OF ECG ABNORMALITIES IN 
1134 MEN, AGE 4564 yr, RENFREW, SCOTLAND 


































Pooling Project Major AbnormalitiesdS cases 
Glucose 0.0025 0.0048 0.51 95.9 
Age 0.0857 0.024 1 3.55*** 54.0 
Systolic pressure 0.0104 0.0060 1.74 148.1 
Relative weight 0.0109 0.0096 1.13 112.4 
Cholesterol - 0.0078 0.0035 -2.26” 218.8 
Cigarettes/day 0.0172 0.0137 1.26 9.4 










+p < 0.05. 
**p < 0.01. 
***p 5 0.001. 
similar trend in the above-median systolic blood pressure group for Pooling Project 
Major Abnormalities but it was not statistically significant. 
Table 6 splits the study group according to smoking habit and shows age-adjusted 
ECG abnormality rates for the quintiles of glucose. There were no apparent trends 
among non-smokers and the trends for high glucose to be associated with higher abnor- 
mality rates among smokers and ex-smokers were not significant. 
Table 7 shows the multiple logistic analysis for ECG abnormalities taking into account 
the variables age, systolic blood pressure, cholesterol, glucose, relative weight, number of 
cigarettes smoked per day, and ex-smoking, which is a variable taking the value ‘0’ for 
TABLE 7A. MULTIPLE LOGISTIC ANALYSIS, PREVALENCE OF ECG ABNORMALITIES IN 
1348 MEN AGE 45-64 yr: INCLUDING THOSE ON ANTI-HYPERTENSIVE TREATMENT 
Variable Coeff. (/I) S.E. 
Non-cases Cases 
t mean mean 
Whitehall Criteria-123 cases 
Glucose 0.0094 0.0038 2.50’ 95.6 
Age 0.0670 0.0177 3.78*** 54.1 
Systolic pressure 0.0109 0.0043 2.54* 148.4 
Relative weight 0.0132 0.0071 1.86 112.2 
Cholesterol 0.0094 0.0026 3.66*** 218.4 
Cigarettes/day 0.0131 0.0103 1.27 9.5 
Ex-smoking 0.2682 0.2505 1.07 
Constant - 12.40 
Pooling Project Major Abnormalities-105 cases 
Glucose 0.0004 0.0040 0.10 96.1 
Age 0.1020 0.0191 5.33*** 54.0 
Systolic pressure 0.0077 0.0046 1.67 148.6 
Relative weight 0.0134 0.0076 1.76 112.4 
Cholesterol - 0.0024 0.0027 -0.88 219.9 
Cigarettes/day 0.0169 0.0111 1.52 9.5 
Ex-smoking 0.3531 0.2692 1.31 













*p < 0.05. 
**p < 0.01. 
***p s 0.001. 
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TABLE 8. QUINTILES, EXTREME VALUES OF GLUCOSE AND 6-yr MORTALITY, 1128 MEN, AGE 45-64, RENFREW, 
SCOTLAND 
Glucose Number 
Quintile of range Of 
glucose (mg/dl) men 
QuintlIe 
1 27-80 222 
2 81-88 241 
3 89-96 211 
4 97-107 227 
5 108-518 227 
Lowest 5% 27-69 57 
Highest 5% 134518 58 
All men 27-518 1128 
*Number of deaths. 































non-smokers and current smokers and ‘1’ for ex-smokers. Cholesterol, age and glucose 
were significantly positively associated with Whitehall abnormalities while cholesterol 
was significantly negatively associated with Pooling Project Major Abnormalities. 
In order to determine whether exclusion of the large group of men on anti-hyperten- 
sive treatment had obscured any associations, the multivariate analyses were re- 
computed including those men (Table 7A). Glucose continued to be positively and sig- 
nificantly associated with Whitehall abnormalities and to show no association with 
Pooling Project Major Abnormalities. The 214 treated hypertensive men added 40 cases 
to the previous 65 Pooling Project Major Abnormalities found in 1134 men. With this 
larger number of cases the previous negative association of cholesterol with the abnor- 
mality was no longer statistically significant. Age remained a significant factor. 
Tables 8-l 1 inclusive show analyses similar to those in Tables 4-7, with 6-yr mortality 
instead of prevalence of ECG abnormalities as the end point. There was no evidence 
from Tables 8, 9 or 10 to suggest that higher mortality rates were associated with higher 
glucose levels. 
TABLE 9. GLUCOSE, SYSTOLIC BLOOD PRESSURE AND 6-yr MORTALITY, 1128 MEN, AGE 45-64, RENFREW, SCOTLAND 
Systolic blood 
pressure (SBP) Glucose Number 6-yr mortality 
and glucose range Of All Coronary 
quintile (mg/dl) men mortality Cardiovascular heart disease 
SBP below 
median (I 146) 
Quint& 
1 27-80 126 2* 31t 0 0 0 0 
2 81-88 148 10 71 6 46 5 40 
3 89-96 104 6 66 
: 
17 2 17 
4 97-107 104 4 47 28 1 21 
5 108-518 97 
2: 
14 0 0 0 0 
All 27-518 579 49 10 20 8 17 
SBP above 
median (> 146) 
Quintile 
1 27-80 96 6 60 5 49 4 37 
2 81-88 93 6 65 2 21 1 10 
3 89-96 107 7 61 2 16 1 8 
4 97-107 123 7 55 3 23 2 15 
5 108-518 130 11 85 7 57 6 50 
All 27-518 549 37 67 19 33 14 25 
All men 27-518 1128 60 59 29 28 22 22 
*Number of deaths 
Wtandardized death rate per 1000. 
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In the multiple logistic analyses in Table 11, age and systolic pressure showed the 
strongest association with mortality. Cigarette smoking (present or past) also showed 
positive association with cardiovascular and coronary mortality. However glucose was 
not found to be associated with any of the mortality endpoints. 
When those on anti-hypertensive medication were included (Table 1 lA), age remained 
positively associated with mortality and glucose showed a slight non-significant negative 
association with CHD mortality. The anomalous finding that, with inclusion of known 
hypertensives, the former strong positive association of systolic pressure with mortality 
disappeared, could be attributed to the lower mean pressure in the treated hypertensives, 
who contributed heavily to the events. 





















































27-80 60 2 
81-88 66 6 
89-96 48 0 
97-107 65 1 
108-518 77 5 
27-518 316 14 



















4 51 3 37 2 23 
9 68 4 29 3 23 
10 118 4 46 3 34 
9 107 4 45 3 37 
4 46 2 23 1 11 














2 33 2 33 
4 54 3 44 
0 0 0 0 
1 12 0 0 
4 66 4 66 
11 37 9 32 













*Number of deaths. 
tstandardized death rate per 1000 
COMMENTS 
In Renfrew, multivariate analyses did not consistently demonstrate an association 
between baseline glycemia and coronary or cardiovascular death rates. Univariate cross- 
sectional analyses showed a positive association between blood glucose and the 
prevalence of ECG abnormality as defined both by the London Whitehall Study and the 
U.S. Pooling Project. Preliminary prevalence data now available from an additional 3188 
males, age 45-64 yr show similar trends in the relation between baseline glucose levels 
and these end points. Both the Renfrew [l] and Paisley [12] studies are prospective, and 
together comprise 15,466 males and females identified by census in the general popula- 
tion. It would seem important that our collaboration continue in order to answer the 
questions that remain unanswered in this report and until sufficient mortality has accu- 
mulated not only in the West of Scotland and Chicago where mortality and morbidity 
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